How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
GP Lenses Market
- By Material Type: Fluoropolymer, Silicone Acrylate, Fluorosilicone Acrylate, Perfluoropolymer
- By Design: Spherical, Toric, Multifocal, Aspheric, Hybrid
- By Wearing Schedule: Daily Wear, Extended Wear, Continuous Wear
- By Application: Keratoconus, Post-Surgical Correction, Astigmatism Correction, Presbyopia Correction, Myopia Control
- By End User: Optometry Clinics, Ophthalmology Clinics, Retail Optical Stores, Online Retailers
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Fluoropolymer leads By Material Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 14 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 293 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.179 →
- 12 Company Profiles 14 players: SWOT & benchmarking p.187 →
Full report · locked preview
Everything inside the GP Lenses Market report
A complete, evidence-based study - 12 chapters and 123 sections covering market size, segmentation across 5 axes, regional analysis and 14 company profiles, forecast to 2033.
Segmentation covered
Material Type 4
Design 5
Wearing Schedule 3
Application 5
End User 4
Companies profiled
Menicon Co. Ltd.
Bausch + Lomb (a division of Bausch Health Companies Inc.)
Contamac Ltd.
Paragon Vision Sciences Inc.
Conoptica Ltd.
Hydron Group
Art Optical Contact Lens Inc.
GP Specialists Inc.
Sun Contact Lens Co. Ltd.
Toyo Optical Co. Ltd.
Mediworks Optical Co. Ltd.
Contex Optical Technologies
+2 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
14 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Menicon Co. Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Bausch + Lomb (a division of Bausch Health Companies Inc.)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Contamac Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Paragon Vision Sciences Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Conoptica Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Hydron Group
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Art Optical Contact Lens Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →GP Specialists Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Sun Contact Lens Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Toyo Optical Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Mediworks Optical Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Contex Optical Technologies
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.220 →Luneau Technology
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Optimum Contact Lens
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$5,627M by 2033 · 10.8% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Fluoropolymer58.4
- Silicone Acrylate8.4
- Fluorosilicone Acrylate16.6
- Perfluoropolymer16.6
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$820.2M → $2,026M · 12.0%
Europe$571.6M → $1,172M · 9.4%
Asia Pacific$521.9M → $1,123M · 10.1%
Latin America$323.1M → $655.2M · 9.2%
Middle East and Africa$248.5M → $614.7M · 12.0%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →10.702026
10.722027
10.742028
10.752029
10.752030
10.772031
10.792032
10.792033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Menicon Co. Ltd.26.5
- Bausch + Lomb (a division of Bausch Health Companies Inc.)15.7
- Contamac Ltd.8.7
- Paragon Vision Sciences Inc.4.7
- Conoptica Ltd.6.6
- Hydron Group9.8
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Material Type23.1%
Design26.1%
Wearing Schedule13.8%
Application18.4%
End User18.5%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America36.2
- Europe21.0
- Asia Pacific20.1
- Latin America11.7
- Middle East and Africa11.0
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Menicon Co. Ltd. | 86 | 90 | 82 | 96 | 82 | 86 | 87 |
| Bausch + Lomb (a division of Bausch Health Companies Inc.) | 68 | 85 | 76 | 73 | 86 | 81 | 78 |
| Contamac Ltd. | 64 | 81 | 85 | 80 | 72 | 81 | 77 |
| Paragon Vision Sciences Inc. | 76 | 75 | 63 | 58 | 62 | 63 | 66 |
| Conoptica Ltd. | 59 | 62 | 58 | 62 | 58 | 67 | 61 |
| Hydron Group | 58 | 61 | 71 | 66 | 58 | 60 | 62 |
| Art Optical Contact Lens Inc. | 43 | 65 | 61 | 48 | 63 | 57 | 56 |
| GP Specialists Inc. | 39 | 35 | 39 | 51 | 35 | 56 | 43 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Menicon Co. Ltd.
- Bausch + Lomb (a division of Bausch Health Companies Inc.)
- Contamac Ltd.
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Menicon Co. Ltd. | ◐ | ✓ | ✓ | ✓ | ✓ | ◐ |
| Bausch + Lomb (a division of Bausch Health Companies Inc.) | − | ✓ | ◐ | ✓ | ✓ | ◐ |
| Contamac Ltd. | ◐ | ◐ | ✓ | ◐ | ◐ | ✓ |
| Paragon Vision Sciences Inc. | ✓ | ✓ | − | − | − | ◐ |
| Conoptica Ltd. | ◐ | ◐ | ◐ | ◐ | ◐ | ◐ |
| Hydron Group | ◐ | − | ✓ | ◐ | − | ◐ |
| Art Optical Contact Lens Inc. | − | ◐ | ◐ | ◐ | ◐ | ◐ |
| GP Specialists Inc. | − | − | − | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Menicon Co. Ltd.87
2Bausch + Lomb (a division of Bausch Health Companies Inc.)78
3Contamac Ltd.77
4Paragon Vision Sciences Inc.66
5Hydron Group62
6Conoptica Ltd.61
7Art Optical Contact Lens Inc.56
8GP Specialists Inc.43
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Menicon Co. Ltd.Bausch + Lomb (a division of Bausch Health Companies Inc.)
Challenger1
Strong scale, closing on the leaders.
Contamac Ltd.
Contender3
Focused players with pockets of strength.
Paragon Vision Sciences Inc.Conoptica Ltd.Hydron Group
Niche2
Specialists in a single segment or region.
Art Optical Contact Lens Inc.GP Specialists Inc.
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Material Type in North America, then scale across GP Lenses Market — a $143M beachhead inside a $2.32B market.
Beachhead (SOM)$143Mobtainable near-term
Serviceable (SAM)$903Mreachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale4 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion86 fit
Fluoropolymer
Best fit — highest urgency & budget in Material Type.
Economic buyer76 fit
Silicone Acrylate
Strong fit — clear ROI and a fast path to value.
End user68 fit
Fluorosilicone Acrylate
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Material Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Design & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Wearing Schedule
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales43%
Partner / channel26%
Digital / self-serve21%
Marketplaces10%
Positioning & messaging
§GTM 2 · p.194 →For Material Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win GP Lenses Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified41%
Sales qualified22%
Evaluation13%
Closed-won5%
$13.1KCAC
$72KLTV
5.5:1LTV : CAC
< 3 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
GP Lenses Market is a durable-growth opportunity — $9.26B by 2033, compounding at 9.3%.
TAM · 2025$4.55Btoday
TAM · 2033$9.26Bforecast
CAGR9.3%2027–2033
Cumulative$60.0Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$9.26BTotal addressable market
SAM$3.60BServiceable available market
SOM$677MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →9.3% CAGR
Demand compounds through 2033, outpacing GDP across Material Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Material Type moving from early to mainstream — durable secular demand.
Consolidation upside
14+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$9.26BLarge & growingTAM by 2033 at 9.3% CAGR
$3.60BServiceable nowreachable with today’s model
$677MBeachhead winobtainable near-term share
14+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$7.23BBear6.0% CAGR
$9.26BBase9.3% CAGR
$11.9BBull12.2% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Design optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
GP Lenses Market — a $8.19B market by 2033. Plan: grow share from 10.0% to 18.5%.
Market size · 2033$8.19Btotal addressable
Market CAGR6.9%2027–2033
Target share18.5%from 10.0% today
Revenue ambition$1.51Bby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 10.0% | 18.5% | On track |
| Revenue | $756M | $1.51B | Ahead |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | On track |
| Gross margin | 33.6% | 45.4% | Behind |
| Customer retention | 89.9% | 92.2% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Material Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Design capability
A defensible second engine — invest in Design to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Material Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Design
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $172M capacity & capability investment
- Greenlight bolt-on M&A in Design
- Authorise North America expansion plan
- Fund R&D program for Material Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossAt risk
- Input-cost & supply riskAhead
- Regulatory / policy changeOn track
- Execution & talentBehind
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the GP Lenses Market conversation — a $12.3B market you can size, segment and defend in minutes.
Market size · 2033$12.3Btotal opportunity
Growth11.0%CAGR to 2033
Addressable buyers1,112+accounts in scope
Typical ROI4.9×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Material Type
Goal Grow share in Material Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →4.9×return on cost, year one
< 4 mopayback period
$75K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
14+players profiled in this market
Coverage includes
Menicon Co. Ltd.Bausch + Lomb (a division of Bausch Health Companies Inc.)Contamac Ltd.Paragon Vision Sciences Inc.Conoptica Ltd.Hydron GroupArt Optical Contact Lens Inc.GP Specialists Inc.+6 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your GP Lenses Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
GP Lenses Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →High-Throughput Micro-Bioreactors Market
Market size, share, segmentation and regional forecast.
$5.8B market · 2025 base year
View reportHigh Throughput Liquid Handling Workstation Market
Market size, share, segmentation and regional forecast.
$4.4B market · 2025 base year
View reportRGP Contact Lenses Market
Market size, share, segmentation and regional forecast.
$633M market · 2025 base year
View reportHigh Throughput Immunodiagnostics Market
Market size, share, segmentation and regional forecast.
$1.6B market · 2025 base year
View reportHigh-Throughput Gene Sequencer Market
Market size, share, segmentation and regional forecast.
$2.0B market · 2025 base year
View reportHigh-throughput Drug Screening Instrument Market
Market size, share, segmentation and regional forecast.
$1.9B market · 2025 base year
View reportHigh Throughput Drug Screening Equipment Market
Market size, share, segmentation and regional forecast.
$2.7B market · 2025 base year
View reportHigh-Throughput Cellular Screening System Market
Market size, share, segmentation and regional forecast.
$5.7B market · 2025 base year
View reportHigh Throughput Antibody Production Services Market
Market size, share, segmentation and regional forecast.
$451M market · 2025 base year
View reportPassive Temperature Controlled Packaging in Pharma Market
Market size, share, segmentation and regional forecast.
$2.8B market · 2025 base year
View reportClinic Dental Market
Market size, share, segmentation and regional forecast.
$4.6B market · 2025 base year
View reportWhite Mineral Oil (Petroleum) Market
Market size, share, segmentation and regional forecast.
$4.6B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.